Ocular Therapeutix
OCUL
#4790
Rank
C$3.06 B
Marketcap
C$13.97
Share price
-1.48%
Change (1 day)
-20.32%
Change (1 year)

Earnings for Ocular Therapeutix (OCUL)

Earnings in 2026 (TTM): -C$0.41 Billion

According to Ocular Therapeutix's latest financial reports the company's current earnings are C$52.03 Million. In 2025 the company made an earning of -C$0.38 Billion a decrease over its 2024 earnings that were of -C$0.28 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Ocular Therapeutix from 2013 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$0.41 Billion7.75%
2025 -C$0.38 Billion37.43%
2024 -C$0.28 Billion139.68%
2023 -C$0.12 Billion13.65%
2022 -C$99.33 Million984.05%
2021 -C$9.17 Million-95.79%
2020 -C$0.22 Billion80.19%
2019 -C$0.13 Billion44.01%
2018 -C$83.87 Million-5.38%
2017 -C$88.63 Million41.79%
2016 -C$62.51 Million12.47%
2015 -C$55.58 Million38.75%
2014 -C$40.06 Million115.12%
2013 -C$18.62 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
SurModics
SRDX
-C$15.67 Million-96.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Anika Therapeutics
ANIK
-C$17.14 Million-95.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Intersect ENT
XENT
-C$0.23 Billion-44.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Haemonetics
HAE
C$0.21 B-153.95%๐Ÿ‡บ๐Ÿ‡ธ USA